These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21813070)

  • 1. Elevated IgG autoantibody production in oligoarticular juvenile idiopathic arthritis may predict a refractory course.
    Stoll ML; Li QZ; Zhou J; Punaro M; Olsen NJ
    Clin Exp Rheumatol; 2011; 29(4):736-42. PubMed ID: 21813070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of juvenile idiopathic arthritis with intra-articular triamcinolone hexacetonide: evaluation of clinical effectiveness correlated with circulating ANA and T gamma/delta + and B CD5+ lymphocyte populations of synovial fluid.
    Lepore L; Del Santo M; Malorgio C; Presani G; Perticarari S; Prodan M; Di Leo G; Leone V; Tommasini A
    Clin Exp Rheumatol; 2002; 20(5):719-22. PubMed ID: 12412208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic profiling of extracellular vesicles in synovial fluid and plasma from Oligoarticular Juvenile Idiopathic Arthritis patients reveals novel immunopathogenic biomarkers.
    Raggi F; Bartolucci M; Cangelosi D; Rossi C; Pelassa S; Trincianti C; Petretto A; Filocamo G; Civino A; Eva A; Ravelli A; Consolaro A; Bosco MC
    Front Immunol; 2023; 14():1134747. PubMed ID: 37205098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of relapse in patients with oligoarticular juvenile idiopathic arthritis in remission off medication.
    Kaplan MM; Kurt T; Polat MC; Sezer M; Ekici Tekin Z; Çelikel E; Güngörer V; Tekgöz N; Karagöl C; Coşkun S; Öner N; Çelikel Acar B
    Eur J Pediatr; 2023 Oct; 182(10):4557-4564. PubMed ID: 37526705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of positive antinuclear antibodies and rheumatoid factor in systemic juvenile idiopathic arthritis points toward an autoimmune phenotype later in the disease course.
    Hügle B; Hinze C; Lainka E; Fischer N; Haas JP
    Pediatr Rheumatol Online J; 2014; 12():28. PubMed ID: 25114627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of selected biomarkers, polymorphisms, and clinical features for oligoarticular juvenile idiopathic arthritis-associated uveitis.
    Pelegrín L; Casaroli-Marano R; Antón J; García de Vicuña MC; Molina-Prat N; Ignacio Aróstegui J; Yagüe J; Ríos J; Adán A
    Ocul Immunol Inflamm; 2014 Jun; 22(3):208-12. PubMed ID: 24131380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-type II collagen antibodies detection and avidity in patients with oligoarticular and polyarticular forms of juvenile idiopathic arthritis.
    Araujo GR; Fonseca JE; Fujimura PT; Cunha-Junior JP; Silva CH; Mourão AF; Canhão H; Goulart LR; Gonçalves J; Ueira-Vieira C
    Immunol Lett; 2015 May; 165(1):20-5. PubMed ID: 25800643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced levels of circulating progenitor cells in juvenile idiopathic arthritis are counteracted by anti TNF-α therapy.
    Martini G; Biscaro F; Boscaro E; Calabrese F; Lunardi F; Facco M; Agostini C; Zulian F; Fadini GP
    BMC Musculoskelet Disord; 2015 Apr; 16():103. PubMed ID: 25925313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating and synovial antibody profiling of juvenile arthritis patients by nucleic acid programmable protein arrays.
    Gibson DS; Qiu J; Mendoza EA; Barker K; Rooney ME; LaBaer J
    Arthritis Res Ther; 2012 Apr; 14(2):R77. PubMed ID: 22510425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti-Tumor Necrosis Factor Therapy.
    Mor-Vaknin N; Rivas M; Legendre M; Mohan S; Yuanfan Y; Mau T; Johnson A; Huang B; Zhao L; Kimura Y; Spalding SJ; Morris PW; Gottlieb BS; Onel K; Olson JC; Edelheit BS; Shishov M; Jung LK; Cassidy EA; Prahalad S; Passo MH; Beukelman T; Mehta J; Giannini EH; Adams BS; Lovell DJ; Markovitz DM
    Arthritis Rheumatol; 2018 Apr; 70(4):594-605. PubMed ID: 29287303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low synovial double negative T and γδ T cells predict longer free-disease survival in oligoarticular JIA.
    Licciardi F; Ceci M; Toppino C; Turco M; Martino S; Ricotti E; Ferro F; Montin D
    Cytometry B Clin Cytom; 2018 May; 94(3):423-427. PubMed ID: 29059705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic value of anti-cyclic citrullinated peptide (CCP) antibodies in children with Juvenile Idiopathic Arthritis.
    Brunner J; Sitzmann FC
    Clin Exp Rheumatol; 2006; 24(4):449-51. PubMed ID: 16956438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The DNA methylation landscape of CD4
    Chavez-Valencia RA; Chiaroni-Clarke RC; Martino DJ; Munro JE; Allen RC; Akikusa JD; Ponsonby AL; Craig JM; Saffery R; Ellis JA
    J Autoimmun; 2018 Jan; 86():29-38. PubMed ID: 28969936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markedly decreased antibody titers against hepatitis B in previously immunised children presenting with juvenile idiopathic arthritis.
    Maritsi D; Vartzelis G; Soldatou A; Garoufi A; Spyridis N
    Clin Exp Rheumatol; 2013; 31(6):969-73. PubMed ID: 23806191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remission rate is not dependent on the presence of antinuclear antibodies in juvenile idiopathic arthritis.
    Glerup M; Herlin T; Twilt M
    Clin Rheumatol; 2017 Mar; 36(3):671-676. PubMed ID: 28097448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Joint hypermobility and oligoarticular juvenile idiopathic arthritis: What relationship?
    Cecchin V; Sperotto F; Balzarin M; Vittadello F; Martini G; Zulian F
    J Paediatr Child Health; 2017 Apr; 53(4):374-377. PubMed ID: 28052441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-α-1,4-D-polygalacturonic acid antibodies as a new biomarker for juvenile idiopathic arthritis.
    Huang J; Wu Z; Quan W; Ye X; Dai X; Luo J; Han X; Li X; Zheng W
    Clin Rheumatol; 2024 Sep; 43(9):2919-2926. PubMed ID: 38997543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel reactive epitope-based antigen targeted by serum autoantibodies in oligoarticular and polyarticular juvenile idiopathic arthritis and development of an electrochemical biosensor.
    Araujo GR; Fujimura PT; Vaz ER; Silva TA; Rodovalho VR; Britto-Madurro AG; Madurro JM; Fonseca JE; Silva CH; Santos PS; Mourão AF; Canhão H; Goulart LR; Gonçalves J; Ueira-Vieira C
    Immunobiology; 2016 May; 221(5):634-40. PubMed ID: 26806845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proinflammatory cytokines in monitoring the course of disease and effectiveness of treatment with etanercept (ETN) of children with oligo- and polyarticular juvenile idiopathic arthritis (JIA).
    Kaminiarczyk-Pyzalka D; Adamczak K; Mikos H; Klimecka I; Moczko J; Niedziela M
    Clin Lab; 2014; 60(9):1481-90. PubMed ID: 25291944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Self-Reported Pain in Juvenile Idiopathic Arthritis as Related to Long-Term Outcomes: Results From the Nordic Juvenile Idiopathic Arthritis Cohort Study.
    Arnstad ED; Rypdal V; Peltoniemi S; Herlin T; Berntson L; Fasth A; Nielsen S; Glerup M; Ekelund M; Zak M; Aalto K; Nordal E; Romundstad PR; Rygg M;
    Arthritis Care Res (Hoboken); 2019 Jul; 71(7):961-969. PubMed ID: 30055093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.